MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 136 filers reported holding MERSANA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.11 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $102,000 | +78.9% | 15,156 | +6.1% | 0.00% | +100.0% |
| Q1 2022 | $57,000 | 0.0% | 14,280 | +55.7% | 0.00% | 0.0% |
| Q4 2021 | $57,000 | -52.5% | 9,173 | +3.6% | 0.00% | -50.0% |
| Q2 2021 | $120,000 | +166.7% | 8,853 | +218.9% | 0.00% | +100.0% |
| Q1 2021 | $45,000 | -67.6% | 2,776 | -53.3% | 0.00% | -86.7% |
| Q2 2020 | $139,000 | +6850.0% | 5,947 | +485.3% | 0.02% | +1400.0% |
| Q3 2019 | $2,000 | -50.0% | 1,016 | +43.5% | 0.00% | -50.0% |
| Q1 2019 | $4,000 | -66.7% | 708 | +3.7% | 0.00% | -50.0% |
| Q2 2018 | $12,000 | – | 683 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
| Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
| Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
| Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
| Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
| NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
| Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
| Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
| FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |